Vicore Pharma's drug candidate, C21 formulation patented
Vicore Pharma’s drug candidate, C21 formulation, currently in a phase 2a trial aimed at people with idiopathic pulmonary fibrosis (IPF), has been patented.
Source: outsourcing-pharma.com
Johan Raud News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Johan Raud. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Johan Raud Today - Breaking & Trending Today
Vicore Pharma Holding AB: Vicore obtains SARS coronavirus patent for C21 in the USA
GOTHENBURG, Sweden, Sept. 22, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders
Source: finanznachrichten.de
Vicore obtains SARS coronavirus patent for C21 in the USA
/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders,...
Source: prnewswire.com